Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 1
2007 2
2008 15
2009 13
2010 14
2011 11
2012 7
2013 12
2014 13
2015 9
2016 17
2017 16
2018 4
2019 5
2020 11
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
Mehrotra DV, Janes HE, Fleming TR, Annunziato PW, Neuzil KM, Carpp LN, Benkeser D, Brown ER, Carone M, Cho I, Donnell D, Fay MP, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Juraska M, Luedtke A, Nason M, Vandebosch A, Zhou H, Cohen MS, Corey L, Hartzel J, Follmann D, Gilbert PB. Mehrotra DV, et al. Ann Intern Med. 2021 Feb;174(2):221-228. doi: 10.7326/M20-6169. Epub 2020 Oct 22. Ann Intern Med. 2021. PMID: 33090877 Free PMC article.
COVID-19 vaccine trials should seek worthwhile efficacy.
Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R; World Health Organization Solidarity Vaccines Trial Expert Group. Krause P, et al. Lancet. 2020 Sep 12;396(10253):741-743. doi: 10.1016/S0140-6736(20)31821-3. Epub 2020 Aug 27. Lancet. 2020. PMID: 32861315 Free PMC article. No abstract available.
Rejoinder.
Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TL, Pfeffer MA, Ellenberg SS. Fleming TR, et al. Clin Trials. 2017 Apr;14(2):126-127. doi: 10.1177/1740774516688917. Epub 2017 Jan 31. Clin Trials. 2017. PMID: 28135837 Free PMC article. No abstract available.
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials.
Follmann D, Fintzi J, Fay MP, Janes HE, Baden L, Sahly HE, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM. Follmann D, et al. medRxiv. 2020 Dec 14:2020.12.14.20248137. doi: 10.1101/2020.12.14.20248137. Preprint. medRxiv. 2020. PMID: 33336213 Free PMC article. Updated.
Response.
Fleming TR. Fleming TR. Clin Trials. 2015 Feb;12(1):21-3. doi: 10.1177/1740774514563356. Clin Trials. 2015. PMID: 25721147 No abstract available.
Design Issues in Transgender Studies.
Hughes JP, Emel L, Hanscom B, Zangeneh S. Hughes JP, et al. J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3(Suppl 3):S248-51. doi: 10.1097/QAI.0000000000001077. J Acquir Immune Defic Syndr. 2016. PMID: 27429191 Free PMC article. Review.
Robust inference for the stepped wedge design.
Hughes JP, Heagerty PJ, Xia F, Ren Y. Hughes JP, et al. Biometrics. 2020 Mar;76(1):119-130. doi: 10.1111/biom.13106. Epub 2019 Nov 1. Biometrics. 2020. PMID: 31237680 Free PMC article.
The Bennett-Orlicz Norm.
Wellner JA. Wellner JA. Sankhya Ser A. 2017 Aug;79(2):355-383. doi: 10.1007/s13171-017-0108-4. Epub 2017 May 30. Sankhya Ser A. 2017. PMID: 30122872 Free PMC article.
135 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page